149 related articles for article (PubMed ID: 6111532)
21. Carvedilol in hypertension: effects on hemodynamics and 24-hour blood pressure.
Lund-Johansen P; Omvik P; Nordrehaug JE; White W
J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S27-34. PubMed ID: 1378146
[TBL] [Abstract][Full Text] [Related]
22. A randomized double-blind study of bisoprolol versus atenolol in mild to moderate essential hypertension.
Dixon MS; Thomas P; Sheridan DJ
Eur J Clin Pharmacol; 1990; 38(1):21-4. PubMed ID: 1970298
[TBL] [Abstract][Full Text] [Related]
23. Comparison of a new vasodilating beta-blocker, carvedilol, with atenolol in the treatment of mild to moderate essential hypertension.
Ruilope LM
Am J Hypertens; 1994 Feb; 7(2):129-36. PubMed ID: 7910028
[TBL] [Abstract][Full Text] [Related]
24. Comparison of central and peripheral haemodynamic effects of dilevalol and atenolol in essential hypertension.
Tham TC; Silke B; Taylor SH
J Hum Hypertens; 1990 Jun; 4 Suppl 2():77-83. PubMed ID: 2370647
[TBL] [Abstract][Full Text] [Related]
25. Haemodynamic findings and response rates to beta-blocker--and diuretic monotherapy in mild and moderate hypertension. A one year randomized, double blind study in 100 men.
Otterstad JE; Erikssen J; Froeland G; Soeyland AK; Saltvedt E
Blood Press; 1992 Dec; 1(4):212-8. PubMed ID: 1345218
[TBL] [Abstract][Full Text] [Related]
26. Renal and systemic effects of atenolol and tertatolol in renal transplant recipients on cyclosporine A.
Branten AJ; Hilbrands LB; van Hamersvelt HW; Koene RA; Huysmans FT
Nephrol Dial Transplant; 1998 Feb; 13(2):423-6. PubMed ID: 9509456
[TBL] [Abstract][Full Text] [Related]
27. Mechanism of antihypertensive action of dilevalol compared with that of "cardioselective" beta-blocking agents.
Strom JA; Vidt DG; Bugni W; Atkins J; Fouad-Tarazi F; Cubbon J; Poland MP
Am J Cardiol; 1989 Jun; 63(19):25I-33I. PubMed ID: 2729125
[TBL] [Abstract][Full Text] [Related]
28. Different patterns of peripheral versus central blood pressure in hypertensive patients treated with β-blockers either with or without vasodilator properties or with angiotensin receptor blockers.
Polónia J; Barbosa L; Silva JA; Bertoquini S
Blood Press Monit; 2010 Oct; 15(5):235-9. PubMed ID: 20577082
[TBL] [Abstract][Full Text] [Related]
29. Predictive value of various parameters for the antihypertensive effect of the beta blocker ICI 66,082 (1).
Meekers J; Missotten A; Fagard R; Demuynck D; Harvengt C; Pas P; Billiet L; Amery A
Arch Int Pharmacodyn Ther; 1975 Feb; 213(2):294-306. PubMed ID: 238480
[TBL] [Abstract][Full Text] [Related]
30. Different hemodynamic effects of celipropol and atenolol in patients with mild to moderate hypertension.
Saner H; Seiler A; Mahler F
Arzneimittelforschung; 1995 Jul; 45(7):790-5. PubMed ID: 8573224
[TBL] [Abstract][Full Text] [Related]
31. Antihypertensive therapy in pregnancy directed by noninvasive hemodynamic monitoring.
Easterling TR; Benedetti TJ; Schmucker BC; Carlson KL
Am J Perinatol; 1989 Jan; 6(1):86-9. PubMed ID: 2910324
[TBL] [Abstract][Full Text] [Related]
32. [Comparative pharmacoclinical study of 2 beta-blockers: atenolol and betaxolol in slight-to-moderate arterial hypertension].
Herpin D; Boutaud P; Ciber MA; Amiel A; Demange J
Ann Cardiol Angeiol (Paris); 1987 Nov; 36(9):487-93. PubMed ID: 2892458
[TBL] [Abstract][Full Text] [Related]
33. Antihypertensive and renal haemodynamic effects of atenolol and nadolol in elderly hypertensive patients.
O'Callaghan WG; Laher MS; McGarry K; O'Brien E; O'Malley K
Br J Clin Pharmacol; 1983 Oct; 16(4):417-21. PubMed ID: 6138058
[TBL] [Abstract][Full Text] [Related]
34. Ambulatory blood pressure during once-daily randomised double-blind administration of atenolol, metoprolol, pindolol, and slow-release propranolol.
Floras JS; Jones JV; Hassan MO; Sleight P
Br Med J (Clin Res Ed); 1982 Nov; 285(6352):1387-92. PubMed ID: 6814568
[TBL] [Abstract][Full Text] [Related]
35. [Short term treatment of essential arterial hypertension with atenolol: effect on the renin-angiotensin-aldosterone system and on hemodynamic parameters].
Indovina I; Salerno L; Licata G; Pepe S; Custro N
Clin Ter; 1983 Feb; 104(3):223-6. PubMed ID: 6861459
[No Abstract] [Full Text] [Related]
36. Treatment of severe hypertension with atenolol and betaxolol with once-daily regimens. Hemodynamic aspects.
Chrysant SG; Chrysant C; Bal IS; Trus J; Hitchcock A
Chest; 1989 Sep; 96(3):499-504. PubMed ID: 2569959
[TBL] [Abstract][Full Text] [Related]
37. The effects of a beta 1-blocking agent, atenolol, on blood pressure, plasma renin activity and prostaglandin F2 alpha excretion in patients with essential hypertension.
Pitkäjärvi T; Ylitalo P; Metsä-Ketelä T; Vapaatalo H
Acta Med Scand; 1979; 206(1-2):107-13. PubMed ID: 484251
[TBL] [Abstract][Full Text] [Related]
38. Catecholamines and heart function in heart transplant patients: effects of beta1- versus nonselective beta-blockade.
Leenen FH; Davies RA; Fourney A
Clin Pharmacol Ther; 1998 Nov; 64(5):522-35. PubMed ID: 9834044
[TBL] [Abstract][Full Text] [Related]
39. Home blood pressure monitoring and changes in plasma catecholamines during once or twice daily treatment with atenolol in patients with mild hypertension.
McGrath BP; Beilin LJ; Schofield T; Benedict CR; Barker NP; Cooper R
Aust N Z J Med; 1979 Aug; 9(4):374-81. PubMed ID: 389223
[TBL] [Abstract][Full Text] [Related]
40. Immediate and short-term hemodynamic effects of diltiazem in patients with hypertension.
Amodeo C; Kobrin I; Ventura HO; Messerli FH; Frohlich ED
Circulation; 1986 Jan; 73(1):108-13. PubMed ID: 3510085
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
